Literature DB >> 34273151

Not All Monoclonal Antibodies for COVID-19 Are Created Equal.

Valentina Stosor1, Michael P Angarone1.   

Abstract

Entities:  

Year:  2021        PMID： 34273151     DOI： 10.1093/infdis/jiab380

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  1 in total

1.  Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection.

Authors:  Mohanad M Al-Obaidi; Ahmet B Gungor; Saman Nematollahi; Tirdad T Zangeneh; Edward J Bedrick; Katherine M Johnson; Nicole E Low-Adegbija; Ruhaniyah Alam; Pooja Rangan; C William Heise; Venkatesh K Ariyamuthu; Aneesha Shetty; Abd Assalam Qannus; Sangeetha Murugapandian; Mehmet M S Ayvaci; Prince Mohan Anand; Bekir Tanriover
Journal:  Open Forum Infect Dis       Date:  2022-04-12       Impact factor: 4.423
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.